Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia.

Saruwatari, Junji; Yasui-Furukori, Norio; Kamihashi, Ryoko; Yoshimori, Yuki; Oniki, Kentaro; Tsuchimine, Shoko; Noai, Madoka; Sato, Yasushi; Nakagami, Taku; Sugawara, Norio; Saito, Manabu; Fujii, Akira; Kajiwara, Ayami; Mihara, Shuichi; Ogata, Yasuhiro; Kaneko, Sunao; Nakagawa, Kazuko

Saruwatari, Junji; Yasui-Furukori, Norio; Kamihashi, Ryoko; Yoshimori, Yuki; Oniki, Kentaro; Tsuchimine, Shoko; Noai, Madoka; Sato, Yasushi; Nakagami, Taku; Sugawara, Norio; Saito, Manabu; Fujii, Akira; Kajiwara, Ayami; Mihara, Shuichi; Ogata, Yasuhiro; Kaneko, Sunao; Nakagawa, Kazuko.

Affiliation

Saruwatari J; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Neuropsychiatr Dis Treat ; 9: 1683-98, 2013.

Article de En | MEDLINE | ID: mdl-24204153

Mots clés

glutathione S-transferase; metabolic syndrome; oxidative stress; polymorphism; schizophrenia; superoxide dismutase 2

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Neuropsychiatr Dis Treat Année: 2013 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google